Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:948257.
doi: 10.1155/2013/948257. Epub 2013 Feb 25.

Metabolic Disorders and Diabetic Complications in Spontaneously Diabetic Torii Lepr (fa) Rat: A New Obese Type 2 Diabetic Model

Affiliations

Metabolic Disorders and Diabetic Complications in Spontaneously Diabetic Torii Lepr (fa) Rat: A New Obese Type 2 Diabetic Model

Yusuke Kemmochi et al. J Diabetes Res. 2013.

Abstract

Spontaneously Diabetic Torii Lepr (fa) (SDT fatty) rat, established by introducing the fa allele of the Zucker fatty rat into SDT rat genome, is a new model of obese type 2 diabetes. Both male and female SDT fatty rats show overt obesity, and hyperglycemia and hyperlipidemia are observed at a young age as compared with SDT rats. With early incidence of diabetes mellitus, diabetic complications, such as nephropathy, retinopathy, and neuropathy, in SDT fatty rats were seen at younger ages compared to those in the SDT rats. In this paper, we overview pathophysiological features in SDT fatty rats and also describe new insights regarding the hematology, blood pressure, renal complications, and sexual dysfunction. The SDT fatty rats showed an increase of leukocytes, especially the monocyte count, prominent hypertension associated with salt drinking, end-stage renal disease with aging, and hypogonadism. Unlike other diabetic models, the characteristic of SDT fatty rat is to present an incidence of diabetes in females, hypertension, and retinopathy. SDT fatty rat is a useful model for analysis of various metabolic disorders and the evaluation of drugs related to metabolic disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Computed tomography analysis at 12 weeks of age (representative tomogram). (a) SDT fatty rat; (b) SDT rat. Yellow: subcutaneous fat; red: visceral fat; blue: lean [14].
Figure 2
Figure 2
Changes in body weights (a) and serum parameters (b) glucose; (c) triglyceride; (d) total cholesterol) in SDT fatty rats, pair-fed SDT fatty rats, and SDT rats. Data represent mean ± standard deviation (n = 6). ## P < 0.01: significantly different from SDT fatty rat. **P < 0.01: significantly different from SDT rat.
Figure 3
Figure 3
Histological analysis, HE stain. Pathological findings such as atrophy and fibrosis in pancreatic islets of female SDT fatty rat at 24 weeks of age. Bar = 50 μm.
Figure 4
Figure 4
Histological analysis. HE stain. Severely progressed glomerular and tubulointerstitial lesions in male SDT fatty rat at 60 weeks of age There are completely sclerotic glomeruli and atrophic tubules with many inflammatory cells in the interstitum. Bar = 100 μm.
Figure 5
Figure 5
Changes in MNCV at 8 (a), 24 (b), and 40 (c) weeks of age in SD rats and SDT fatty rats. Data represent mean ± standard deviation (n = 5). *P < 0.05, **P < 0.01: significantly different from SD rat.
Figure 6
Figure 6
Changes in serum osteocalcin (a), (c) and urine deoxypyridinoline (b), (d) in SD rats and SDT fatty rats. Data represent mean ± standard deviation (Male: n = 5, Female: n = 10). *P < 0.05, **P < 0.01: significantly different from SD rat.
Figure 7
Figure 7
Changes in BMD (a), (c) and BMC (b), (d) in SD rats and SDT fatty rats. Data represent mean ± standard deviation (Male: n = 5, Female: n = 10). *P < 0.05, **P < 0.01: significantly different from SD rat.
Figure 8
Figure 8
Histological analysis of uterus, HE stain. (a) SD rats and (b) SDT fatty rats at 12 weeks of age. Bar = 1 mm [26].
Figure 9
Figure 9
Histological analysis of vagina, HE stain. (a) SD rats and (b) SDT fatty rats at 12 weeks of age. Bar = 200 μm [26].

References

    1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20(7):1183–1197. - PubMed
    1. Cavaghan MK, Ehrmann DA, Polonsky KS. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. Journal of Clinical Investigation. 2000;106(3):329–333. - PMC - PubMed
    1. Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420(6913):333–336. - PubMed
    1. Sasase T, Morinaga H, Abe T, et al. Protein kinase C beta inhibitor prevents diabetic peripheral neuropathy, but not histopathological abnormalities of retina in Spontaneously Diabetic Torii rat. Diabetes, Obesity and Metabolism. 2009;11(11):1084–1087. - PubMed
    1. Fukuda S, Ohta T, Sakata S, et al. Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551. Diabetes, Obesity and Metabolism. 2010;12(4):299–306. - PubMed

LinkOut - more resources